Your immune system with a good roadmap

Join Myeloid Therapteutics in studying the potential of this breakthrough science

 

Organizing principle

Placeholder for graphics

Introduce main characters

Myeloid cells

Placeholder for graphics

Receptors

Explain myeloid cell importance to the science

Why Myeloid Cells?

Placeholder for graphics

Phagocytosis

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat,

ATAK™ MECHANISM OF ACTION

Explain how ATAK™ works 

ATAK™

in action

Big graphic that shows all the moving parts interacting. 

 

Recommend creating animation

MOA graphics

 

Myeloid Therapeutics:

The future of immuno-oncology

 

ATAK™ Preclinical

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat,

ATAK™ Rational for Clinical

Proprietary Fcg- PI3K Myeloid ATAK™ construct shows potent phagocytic/anti-tumor activity ...

PIVOTAL STUDIES

  • PHASE Ia

    Single arm open-label clinical trial of MT-101 in subjects with advanced CD5+ expressing T cell lymphoma malignancies

    Key Endpoints:

    Primary

    Secondary

    Safety at 10 weeks

    Objective response rate/

    T cell depletion/CD5 biomarker

  • PHASE Ib

    Single arm open-label clinical trial of MT-102 in subjects with advanced HER2+ expressing gatric/GEJ malignancies

    Key Endpoints:

    Primary

    Secondary

    Safety at 10 weeks

    Objective response rate/HER2 biomarker

© 2020,   Myeloid Therapeutics.  All rights reserved.

  • LinkedIn
  • Instagram
  • Twitter

GET IN

TOUCH

300 Technology Square, Suite 203  Cambridge, MA 02139